Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction

New Microbiologica

Volumn 23, Issue 1, 2000, Pages 37-45

  Cusumano, V ^a   Fera, M T ^a   Carbone, M ^a   Anzani Ciliberti, F ^a   Bellantoni, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; ERYTHROGENIC TOXIN; EXOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MEMBRANE PROTEIN; SPEA PROTEIN, STREPTOCOCCUS PYOGENES; TEICHOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; BLOOD CELL; CELL CULTURE; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

BACTERIAL PROTEINS; BLOOD CELLS; CELLS, CULTURED; CYTOKINES; EXOTOXINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033642959     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ANDERSSON, J., NAGY, S., BJORK, L., ABRAMS, L., HOLM, S., and ANDERSSON, U. (1992). Bacterial toxin-induced cytokine production studied at the single-cell level. Immunological Reviews, 127, 69-96..
2. BARTTER, T., DACAL, A., CARROLL, K., and CURLEY, F.J. (1988). "Toxic Strep. Syndrome". A manifestation of group A streptococcal infection. Archives of Internal Medicine, 148, 1421-1424.
3. BHAKDI, S., KLONISH, T., NUBER, P., and FISHER, W. (1991). Stimulation of monokine production by lipoteichoic acids. Infection and Immunity, 59, 4614-4620.
4. BISNO, A.L. (1990). The resurgence of acute rheumatic fever in The United State. Annual Rev iew of Medicine, 41, 319-329.
5. BOHACH, G.A., FAST, D.J., NELSON, R.D., and SCHLIEVERT, P.M. (1990). Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and relative illnesses. Critical Review in Microbiology, 17, 251-272.
6. BONE, R.C. (1993). Gramnegative sepsis: a dilemma of modern medicine. Clinical Microbiology Reviews, 6, 57-68.
7. BRUNSON, K.W., and WATSON, D.W. (1974). Pyrogenic specificity of streptococcal exotoxins, Staphylococcal enterotoxin, and gram-negative endotoxin. Infection and Immunity, 10, 347-351.
8. CHOMARAT, M., CHAPUIS, C., LEPAPE, A., and BERNARD, F. (1990). Two cases of severe infection with beta-haemolytic group A streptococci associated with a toxic-shock like syndrome. European Journal of Clinical Microbiology Infectious Diseases, 9, 901-903.
9. CONE, L.A., WOODARD, D.R., SCHLIEVERT, P.M., and TOMORY, G.S. (1987). Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. The New England Journal of Medicine, 317, 146-149.
10. COURTNEY, H., OFEK, I., SIMPSON, W.A., and BEACHEY, E.H. (1981). Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood. Infection and Immunity, 32, 625-631.
11. DE KIMPE, S.J., KENGATHARAN, M., THIEMERMANN, C., and VANE, J.R. (1995). The cell wall components peptiglycan and lipoteichoic acid from Staphylococcus aureus act in sinergy to cause shock and multiple organ failure. Proceedings of the National Academy of Sciences of the USA, 92, 10359-10363.
12. FREDENBERG, J., and GALANOS, G. (1991). Tumor necrosis factor alpha mediates lethal activity of killed gram-positive bacteria in D-galactosamine-treated mice. Infection and Immunity, 59, 2110-2115.
13. GERLACH, D, KNÖLL, H., KÖHLER, W., and OZEGOWSKI, J.H. (1981). Isolation and characterization of erythrogenic toxins of Streptococcus pyogenes. 3. Comparative studies of type A eythrogenic toxins. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A., Medical, 250, 277-286.
14. GLAUSER, M.P., ZANETTI, G., BAUMGARNER, J.D., and COHEN, J. (1991). Septic shock: Pathogenesis. Lancet, 1, 732-736.
15. HACK, C.E., HART, M., STRACK VAN SCHIJNDEL, R.J., ANKE EERENBERG, J.M., NUIJENS, J.H., THIJS, L.J., and AARDEN, L.A. (1992). Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infection and Immunity, 60, 2835-2842.
16. HACKETT, S., and STEVENS, D. (1992). Streptococcal toxic shock syndrome: syntesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. Journal of Infectious Diseases, 165, 879-885.
17. HACKETT, S., and STEVENS, D. (1993). Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta-syntesis. Journal of Infectious Diseases, 168, 232-235.
18. HAUSER, A.R., STEVENS, D.L., KAPLAN, E.L., and SCHLIEVERT, P.M. (1991). Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. Journal of Clinical Microbiology, 29, 1562-1567.
19. HOGE, C.W., SCHWARTZ, B., TALKINGTON, D.L., BREIMAN, R.F., MACNEILL, E.M., and ENGLENDER, S.J. (1993). The changing epidemiology of invasive group A Streptococcal infections and the emergence of Streptococcal toxic shock-like syndrome. A retrospective population-based study. The Journal of the American Medical Association, 269, 384-389.
20. HOLM, S.E., NORRBY, A., BERGHOLM, A.M., and NORGREN, M. (1992). Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. Journal of Infectious Diseases, 166, 31-37.
21. KELLER, R., FISHER, W., KEIST, R., and BASSETTI, S. (1992). Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infection and Immunity, 60, 3664-3672.
22. KIM, Y.B., and WATSON, D.W. (1972). Streptococcal exotoxins: biological and pathological properties, p. 33-50. In L.W. Wannamaker and J.H. Matsen (ed), Streptococci and Streptococcal diseases. Recognition, understanding and management. Academic Press, Inc., New York.
23. KOTB, M. (1992). Role of superantingens in the pathogenesis of infectious disease and their sequelae. Current Opinion in Infectious Diseases, 5, 364-374.
24. LEVY, R., KOBT, M., NAGAUKER, O., MAJUMDAR, G., ALKAN, M., OFEK, I., and BEACHEY, E.H. (1990). Stimulation of oxidative burst in human monocytes by lipoteichoics acid. Infection and Immunity, 58, 566-568.
25. MARTY, C., MISSET, B., TAMION, F., FITTING, C., CARLET, J., and CAVAILLON, J.M. (1994). Circulating interleukin 8 concentration in patients with multiple organ failure of septic and non septic origin. Critical Care in Medicine, 22, 673-679.
26. MÜLLER-ALOUF, H., ALOUF E.F., GERLACK, D., OZEGOWSKI, J.M., FITTING, C., and CAVAILLON, J.M. (1994). Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erithrogenic toxins, heat killed streptococci and lipopolysaccaride. Infection and Immunity, 62, 4915-4921.
27. MURAI, T., OGAWA, Y., KAWASAKI, H., and KANOH, S. (1987). Physiology of the potentation of lehal endotoxin shock by streptococcal pyrogenic exotoxin in rabbits. Infection and Immunity, 55, 2456-2460.
28. MUSSER, J.M., HAUSER, A.R., KIM, M.H., SCHLIEVERT, P.M., NELSON, K., and SELANDER, R.K. (1991). Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proceedings of the National Academy of Science of the USA, 88, 2668-2672.
29. NADAL, D., LAUENER, R.P., BRAEGGER, C.P., KAUFHOLD, A., SIMMA, B., LÜTTICKEN, R., and SEGER, R.A. (1993). T cell activation and cytokine release in streptococcal toxic shock-like syndrome. Journal of Pediatrics, 122, 727-729.
30. NORBY-TEGLUND A., NEWTON, D., KOTB, M., HOLM, S.E., and NORGREN, M. (1994). Super-antigenic properties of the group A streptococcal exotoxin Spe F (MF). Infection and Immunity, 62, 5227-5233.
31. NORBY-TEGLUND A., NORGREN, M., HOLM, S.E., ANDERSSON, U., and ANDERSSON, J. (1994). Similar cytokine induction profile of a novel streptococcal mitogenic factor, MF, and pyrogenic exotoxins A and B. Infection and Immunity, 62, 3731-3738.
32. PARSONNET, J. (1989). Mediators in the pathogenesis of toxic shock syndrome: overview. Journal of Infectious Diseases, 11 (Suppl. 1), 5263-5269.
33. ROSENTHAL, R.S., and DZIARSKI, R. (1994). Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods in Enzymology, 235, 253.
34. SCHLIEVERT, P.M. (1993). Role of superantigens in human disease. Journal of Infectious Diseases, 167, 997-1002.
35. SIMPSON, W.A., OFEK, I., and BEACHEY, E.H. (1980). Binding of streptococcal lipoteichoic acid to the fatty acid bindings sites on serum albumin. Journal of Biological Chemistry, 255, 6092-6097.
36. STEVENS, D. L. (1992). Invasive group A streptococcus infections. Clinical Infectious Diseases, 14, 2-13.
37. STEVENS, D.L., TANNER, M.H., WINSHIP, J., SWARTS, R., RIES, K.M., SCHLIEVERT, P.M., and KAPLAN, E. (1989). Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. The New England Journal of Medicine, 321, 7-10.
38. TORRE, D., PUGLIESE, A., SPERANZA F., FIORI, G.P., PERVERSI, L., MARONE, P, and TAMBINI, R. (1993). Interferons-γ levels in serum and bronchoalveolar lavage fluid of mice infected with Bordetella pertussis. Journal of Infectious Diseases, 167, 762-765.